SGLT-2 Inhibitors GLP-1 Agonists Mechanism of Action Examples Route of Administration Effect on Weight Hypoglycemia Risk Cardiovascular Benefit Effect on Lowering HbA1c Side Effects Renal Considerations Cost Use in Type 2 Diabetes Weight Management Indication DPP-4 Inhibitors (AKA Gliptins) Mechanism of Action Examples Route of Administration Effect on Weight Hypoglycemia Risk Cardiovascular Benefit Effect on Lowering HbA1c Side Effects Renal Considerations Cost Use in Type 2 Diabetes Weight Management Indication SGLT-2 Inhibitors Mechanism of Action Examples Route of Administration Effect on Weight Hypoglycemia Risk Cardiovascular Benefit Effect on Lowering HbA1c Side Effects Renal Considerations Cost Use in Type 2 Diabetes Weight Management Indication Using advanced GLP-1 technology, our Sherman Oaks Medspa provides physician-guided treatment that supports appetite control, glucose balance, and long-term wellness

Beyond the physical perks, they leave you with a sense of well-being, helping you feel more vibrant, focused, and ready to conquer the day
The broad appeal of these drugs is showcased by the Food and Drug Administrations approval of electrophilic drugs that act by forming covalent bonds against cancer-relevant targets such as BTK 30 , EGFR 31 or KRAS G12C (ref
Nagashima Y, Ohaki Y, Tanaka Y, Sumino K, Funabiki T, Okuyama T, et al